Top Markets
Coin of the day
Epigenomics AG Epigenomics AG

Epigenomics AG

ECX
Rang in Aktien #38936
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
Aktienkurs
$0.83030862
Zuletzt synchronisiert: 2024-06-27
Marktkapitalisierung
$726.64K
Veränderung (1 Tag)
-1.35%
Veränderung (1 Jahr)
0.00%
Land
DE
Handel Epigenomics AG (ECX)

Kategorie

Kursverlauf für Epigenomics AG (ECX)
Höchster Schlusskurs: $1.42 am 2024-06-01

Niedrigster Schlusskurs: $761.72 am 2014-09-01
Kursverlauf der Aktie von Epigenomics AG von 2014 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2024 -40.31%
2023 -70.25%
2022 -39.44%
2021 -83.30%
2020 -68.68%
2019 -24.83%
2018 -54.25%
2017 -3.39%
2016 90.76%
2015 -58.46%
2014 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$592.67 22.19%
US
$203.74 -3.08%
US
$23.08 67.91%
CN
$561.65 -14.11%
US
$309.55 95.37%
US